Skip to main content
Site Logo
Search site
Search
search
Home
PDL / PA
expand_more
Preferred Drug Lists
PA Forms
Prior Authorization Criteria
New Drug Process
Policy for Review of Drug Status
Appeals & Exception to Policy
CDC Guidelines
(External link)
Info Letters / Provider Info
expand_more
Informational Letters
Latest news
Listserv
Fax Confidentiality Certificate
Billing Information
expand_more
Billing / Quantity Limits
340B
Frequently Asked Questions
Payer Sheet
Committee / Public Comments
expand_more
P&T Committee Information
Public Comments
Drugs for Rare Diseases
Rebate Info
Home
PDL / PA
expand_more
Preferred Drug Lists
PA Forms
Prior Authorization Criteria
New Drug Process
Policy for Review of Drug Status
Appeals & Exception to Policy
CDC Guidelines
(External link)
Info Letters / Provider Info
expand_more
Informational Letters
Latest news
Listserv
Fax Confidentiality Certificate
Billing Information
expand_more
Billing / Quantity Limits
340B
Frequently Asked Questions
Payer Sheet
Committee / Public Comments
expand_more
P&T Committee Information
Public Comments
Drugs for Rare Diseases
Rebate Info
expand_more
expand_more
Home
Section
P&T Committee Information
April 17, 2025
Related files
Final agenda
Draft PDL - April 17, 2025
Reports
There are no files currently available.
Drug monographs
Alhemo
Alyftrek
Aqneursa
Cobenfy
Crenessity
Duvyzat
Hympavzi
Miplyffa
Yorvipath
Zepbound
Drug class reviews
There are no files currently available.
Archive
Tentative Agenda - revised
Tentative Agenda
Draft PDL - April 17, 2025
keyboard_arrow_up
back to top
back to top
keyboard_arrow_up